trending Market Intelligence /marketintelligence/en/news-insights/trending/S60wHov8uLkfIQmbdMt3QA2 content esgSubNav
In This List

Marina Biotech adds board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Marina Biotech adds board member

Philippe Calais was elected to the board of Marina Biotech Inc., which he will join effective Jan. 1, 2017.

Calais is CEO of Isarna Therapeutics GmbH.

The company also said that Joseph Ramelli will transition from interim CEO to permanent chief executive. Ramelli will step down from the board to keep the board size at five members.